Research on starting semaglutide consistently emphasizes the importance of gradual dose increases for minimizing all side effects, not just allodynia
Controversy continues about the causes of this disease
In contrast, mild-to-moderate major depressive disorder (PHQ-9 3 months) and into nociceptive, neuropathic, and nociplastic categories, each demarcated by distinctive mechanisms, clinical manifestations, diagnostic protocols, and therapeutic interventions
Current research shows promising results for Retatrutide, but the two medications have been studied in different clinical trials, making direct comparisons difficult
By enhancing natural hormone output, Sermorelin and Ipamorelin optimize fat metabolism while preserving muscle